Accelerate Your Biologics Discovery With Immunogenicity Prediction

Accelerate your biologics discovery with immunogenicity prediction [WEBINAR]

Miltenyi Biotec

Predicting and Taming Immunogenicity: Complex Biologic Considerations

Predicting and Taming Immunogenicity: Strategies for your Biologic Drug

Jochem Gokemeijer: Immunogenicity risk assessment tool box for biologics drug development

ProImmune thinkpeptides

Immunogenicity overview of therapeutic biologics

Creative Biolabs

In-vitro immunogenicity prediction [WEBINAR]

Miltenyi Biotec

Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop

U.S. Food and Drug Administration

Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop

U.S. Food and Drug Administration

Predicting and Taming Immunogenicity: What is an Integrated Summary of Immunogenicity (ISI)?

Webinar - Bispecific Antibodies: The Next Generation of Antibody Therapeutics

GenScript USA Inc.

Explore Antibody Discovery with Geneious Biologics

Timothy Hickling: Immunogenicity of biotherapeutics: why do we care and where do we stand

ProImmune thinkpeptides

Accelerate GPCR Antibody Discovery with Synthetic DNA Technologies | Melina Mathur

Twist Bioscience

Anti-Idiotypic Antibody Platforms for Accelerating Antibody Drug Discovery

GenScript USA Inc.

Predicting and Taming Immunogenicity: Overview of Immunogenicity & ADA Assays

Antibody drug development challenges & solutions

GenScript USA Inc.

Tim Hickling: Application of Immunogenicity Prediction and Mitigation for Biotherapeutic Development

ProImmune thinkpeptides

Daron Forman: The use of immunogenicity risk assessment tools for lead optimization of biologics

ProImmune thinkpeptides

Tim Hickling: Applying in vitro immunogenicity assays to predict clinical immunogenicity

ProImmune thinkpeptides

Antibody Discovery and Development Efforts Fueling the Future of Diagnostic Testing

Twist Bioscience